piperonyl butoxide has been researched along with triclabendazole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballent, M; Lanusse, C; Lifschitz, A; Sallovitz, J; Scarcella, S; Virkel, G | 1 |
| Alvarez, LI; Brennan, GP; Devine, C; Fairweather, I; Hoey, E; Lanusse, CE; Trudgett, A | 1 |
2 other study(ies) available for piperonyl butoxide and triclabendazole
| Article | Year |
|---|---|
Inhibition of cytochrome P450 activity enhances the systemic availability of triclabendazole metabolites in sheep.
Topics: Animals; Animals, Newborn; Anthelmintics; Area Under Curve; Benzimidazoles; Biological Availability; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme Inhibitors; Female; Ketoconazole; Methimazole; Piperonyl Butoxide; Random Allocation; Sheep; Triclabendazole | 2009 |
Piperonyl butoxide enhances triclabendazole action against triclabendazole-resistant Fasciola hepatica.
Topics: Animals; Benzimidazoles; Cell Membrane; Cytochrome P-450 Enzyme Inhibitors; Drug Combinations; Drug Synergism; Enzyme Inhibitors; Fasciola hepatica; Fascioliasis; Giant Cells; Golgi Apparatus; In Vitro Techniques; Liver Diseases, Parasitic; Microscopy, Electron, Transmission; Mitochondria; Piperonyl Butoxide; Triclabendazole | 2011 |